Press Release
Feb 13 2025
FORE Biotherapeutics to Participate in the Raymond James Private Biotech Symposium
Read more
Press Release
Mar 31 2025
FORE Biotherapeutics to Present Two Plixorafenib Abstracts at the American Association for Cancer Research Annual Meeting 2025
Read more
Press Release
Jan 09 2025
FORE Biotherapeutics Highlights Recent Pipeline Achievements for its Targeted-Oncology Program and Provides Strategic Objectives for 2025
Read more
Press Release
Dec 19 2024
FORE Biotherapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Read more
Press Release
Dec 05 2024
FORE Biotherapeutics to Participate in the Wells Fargo Virtual Private Biotech Symposium
Read more
Press Release
Nov 07 2024
FORE Biotherapeutics to Participate in Upcoming Investor Conferences
Read more
Press Release
Oct 08 2024
FORE Biotherapeutics Presents at RBC Capital Markets 2024 Virtual Biotechnology Private Company Conference
Read more
Press Release
Sep 26 2024
FORE Biotherapeutics Presents at UBS 2024 Biotechnology Private Company Virtual Symposium
Read more
Press Release
Sep 04 2024
FORE Biotherapeutics to Participate in Upcoming Investor Conferences
Read more
Press Release
Aug 12 2024
FORE Biotherapeutics Names Michael Byrnes as Chief Financial Officer
Read more